In a study involving de novo MDS patients, the activation of NF-κB was significantly associated with increased ferritin (≥ 500 ng/mL), percentage of blasts (≥ 5%) and IL-8 levels [31]. The gene discussed is NFKB1; the disease is myelodysplastic syndrome.